Investornewsbreaks Senestech Inc. (NASDAQ: SNES) Offering Proven Way To Reduce Rat Populations By Over 90%


(MENAFN- Investor Brand Network) SenesTech (NASDAQ: SNES) , the inventor of the only EPA-registered contraceptive for male and female rats, recognizes the risks associated with growing rodent populations in cities and areas with a substantial human population.“With its fertility control products, SenesTech offers a proven way for entire cities and urban areas to reduce rat populations by over 90%. Available in a variety of delivery systems, SenesTech's products allow for easy and efficient product deployment, an approach that is achieving significant acceptance in the market. SenesTech's approach is much needed throughout the industrialized and agricultural world, particularly factoring in how rodents can directly transmit a range of pathogens and diseases... SenesTech has been advocating non-lethal rodent birth control products added to or separate from existing integrated pest management plans. Their products can be used separately, or in conjunction with additional rodent control methods,” a recent article reads.“The most [effective approach] is combining the elements of integrated pest management and having them work together and support each other,” Joel Fruendt, SenesTech's CEO, was quoted as saying.

To view the full article, visit

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. The company is an expert in fertility control to manage animal pest populations. It invented ContraPest(R), the only U.S. EPA-registered contraceptive for male and female rats, and Evolve(TM), an EPA-designated minimum risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable. For more information about the company, visit .

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company's newsroom at S

About InvestorWire

InvestorWire
(“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within
the
Dynamic Brand Portfolio
@
IBN
that delivers :
(1) access to a vast network of wire solutions via
InvestorWire
to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ;
(2) article and
editorial syndication to 5,000+ outlets ;
(3) enhanced
press release enhancement
to ensure maximum impact ;
(4)
social media distribution
via IBN to millions of social media followers ;
and (5) a full array of tailored
corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published:
/Disclaimer

InvestorWire
Los Angeles, CA

310.299.1717 Office
...

InvestorWire is powered by
IBN

MENAFN17052024000224011066ID1108226984


Investor Brand Network

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.